ArticleBMJ global health2025
Public-private dialogue: an essential approach to engage non-state actors in a mixed health system.
Article in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Evidence shows that low-income and middle-income country (LMIC) governments are still facing challenges to systematically engage the private sector in health. Barriers to greater interactions between public and private health partners include mistrust of the private health sector's motives and misunderstanding of the profit motive, based on deep-rooted philosophical beliefs and personal experiences.This paper examines the implementation of public-private dialogue (PPD) as a means for addressing the aforementioned barriers facing the engagement of the private sector in health in LMICs. The paper responds to a research gap surrounding the process of conducting PPD in health by defining PPD, describing the associated risks and benefits learnt from country examples and providing tactics for leveraging the benefits while addressing the potential risks of PPD. The paper also emphasises the similarities between the process to conduct PPDs in health compared with other social and economic sectors, with the exception of one additional risk, namely 'institutional misalignment'. This additional risk observed in the health sector can be attributed to the limited capacity of Ministries of Health to govern the private sector and the diversity and fragmentation of private health sector entities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.